| Literature DB >> 32832440 |
Prekshi Bansal1, Kabir Sardana1, Gauri Vats1, Lokesh Sharma2, Umesh Chandra Garga3, Ananta Khurana1.
Abstract
BACKGROUND: Numerous triggers have been implicated in adult female acne including endogenous (hormonal dysfunction and genetic predisposition) and exogenous causes (drugs, cosmetics, sunscreens, stress, and smoking). AIMS: To evaluate the role of various trigger factors in adult female acne and to analyze the androgenic hormone pattern including anti-Mullerian hormone (AMH) in these patients.Entities:
Keywords: Adult female acne; cosmetics; diet; hyperandrogenemia; stress; trigger factors
Year: 2020 PMID: 32832440 PMCID: PMC7413461 DOI: 10.4103/idoj.IDOJ_500_19
Source DB: PubMed Journal: Indian Dermatol Online J ISSN: 2229-5178
Proforma
| History of presenting acne complaint | |
|---|---|
| History of acne trigger factors (subjective) | None |
| What causes or exacerbates acne according to you? | Cosmetics |
| Drugs* | |
| Prescription/nonprescription (including vitamin supplements) | |
| Hormonal/nonhormonal | |
| Oily food (patient perception) | |
| Premenstrual flare | |
| Dietconsumption (days/week) | What type of milk do you consume and how frequently? (skimmed/partially skimmed/whole) |
| What are the various dairy products (cheese/yogurt) you consume and how frequently? | |
| What are the various starchy food and processed foods you consume (pasta/bread/rice) and how frequently? | |
| What are the various oily foods you consume and how frequently? | |
| How frequently do you eat fruits, vegetables, fish, and dietary fibers? | |
| Assessment of glycemic index of foods† | |
| Cosmetics (frequency and duration) | Which sunscreen do you use and how frequently? |
| Which fairness cream do you use and how frequently? | |
| Which foundation do you use and how frequently? | |
| What is the frequencyof getting Facial? | |
| Assessment of cosmetics for comedogenic ingredients‡ | |
| Stress¦ | None |
| Mild | |
| Moderate | |
| Severe | |
| Sleep-wake cycle‖ | Adequate |
| Inadequate | |
| Smoking | Smoker/nonsmoker |
*Drug history included androgens, anticonvulsants, antidepressants, antipsychotics, antitubercular drugs, and antivirals. Drugs causing acneiform eruptions such as corticosteroids were excluded (only acne vulgaris assessed). †based on glycemic index chart[13], ‡Based on data derived from previous studies[14][15], §Perceived stress scale, Mild—low stress: Moderate—moderate stress; Severe—high perceived stress. ‖Pittsburgh sleep quality index (PSQI) score >5—inadequate sleep (poor sleepers)
Frequency table of subjective acne trigger factors
| Aggravation factor | Number of women | Percentage |
|---|---|---|
| Nil | 77 | 64.17 |
| Cosmetics | 2 | 1.67 |
| Drugs | 1 | 0.83 |
| Oily food | 3 | 2.50 |
| Premenstrual flare | 36 | 30 |
| Travel | 1 | 0.83 |
| Total | 120 | 100 |
Figure 1An analysis of trigger factors in adult female acne based on objective evaluation (X-axis—trigger factors, Y-axis—the percentage of affected women)
Cosmetics usage in total acne population
| Cosmetics usage | Sample size | Mean±SD | Median | Min-max | Interquartile range |
|---|---|---|---|---|---|
| Sunscreenuse duration (month) | 6 | 10.33±12.68 | 6 | 2-36 | 4-8 |
| Sunscreenuse frequency (days) | 6 | 25.83±3.54 | 25 | 21-30 | 24-30 |
| Fairness cream use duration (month) | 20 | 29.7±34.57 | 12 | 20-120 | 3-54 |
| Fairness cream use frequency (days) | 20 | 24.95±7.67 | 29 | 4-30 | 25-30 |
| Foundationuse duration (month) | 20 | 21.5±25.82 | 12 | 2-120 | 6-24 |
| Foundationuse frequency (days) | 20 | 9±10.63 | 4 | 1-30 | 2-15 |
| Facial duration (month) | 16 | 7.56±5.37 | 6 | 2-24 | 5-10 |
| Facial frequency (days) | 16 | 1.25±0.45 | 1 | 1-2 | 1-1.500 |
Frequency: Days/month, duration: number of months. Frequency of sunscreen usage was highest while duration of sunscreen usage was highest
Figure 2Persistent acne was associated with increased frequency of foundation usage
Hormonal analysis of total acne population
| Hormones | Sample size | Mean±SD | Median | Min-max | Interquartile range | Normal value |
|---|---|---|---|---|---|---|
| 17OHP (ng/mL) | 120 | 1.56±0.68 | 1.5 | 0.33-5.74 | 1.231-1.727 | 0.2-1.3 |
| DHEAS (µg/mL) | 120 | 1.94±0.88 | 1.82 | 0.46-5.4 | 1.305-2.400 | 0.48-2.75 |
| TT (nmol/L) | 120 | 1.07±0.78 | 0.84 | 0.16-6.06 | 0.640-1.295 | <1.89 |
| SHBG (nmol/L) | 120 | 53.61±34.39 | 44.35 | 7-230 | 31.700-66.350 | 11.7-137.2 |
| FAI | 120 | 2.97±3.31 | 1.9 | 0.27-26.46 | 1.126-3.628 | <5 |
| AMH (ng/mL) | 120 | 4.13±3.26 | 3.44 | 0.01-17.2 | 1.715-5.710 | 1.62-5.1 |
| LH (mIU/mL) | 120 | 5.73±3.45 | 5.01 | 0.22-24.21 | 3.765-6.705 | 0.8-15.5 |
| FSH (mIU/mL) | 120 | 6.36±2.23 | 6.1 | 0.86-14.3 | 5.150-7.385 | 1.3-23.4 |
| LH/FSH ratio | 120 | 0.97±0.64 | 0.8 | 0.23-4.03 | 0.604-1.066 | <2 |
| Prolactin (ng/mL) | 120 | 16±15.07 | 13.05 | 2.8-152.8 | 10.350-17.300 | 3-18.6 |
| TSH (mIU/mL) | 120 | 2.9±1.8 | 2.6 | 0.33-9.98 | 1.515-3.785 | 0.5-5 |
Data were expressed as mean±standard deviation (SD). 17-OHP: 17-hydroxyprogesterone; DHEAS: Dehydroepiandrosterone sulfate; TT: total testosterone; SHBG: sex hormone-binding globulin; FAI: free androgen index; AMH: anti-Mullerian hormone; LH: luteinizing hormone; FSH: follicle-stimulating hormone; TSH: thyroid-stimulating hormone
Figure 3A depiction of the percentage of patients with deranged hormones (X-axis—hormonal parameters, Y-axis—the percentage of women with hormonal derangement). 17-OHP: 17-hydroxyprogesterone; DHEAS: dehydroepiandrosterone sulfate; SHBG: sex hormone-binding globulin; FAI: free androgen index; LH: luteinizing hormone; FSH: follicle-stimulating hormone; AMH: anti-Mullerian hormone